Анналы клинической и экспериментальной неврологии (Feb 2017)

Myeloproliferative diseases and ischemic stroke

  • M. M. Tanashyan,
  • P. I. Kuznetsova,
  • O. V. Lagoda,
  • A. A. Shabalina,
  • I. N. Subortseva,
  • A. L. Melikyan

DOI
https://doi.org/10.17816/psaic181
Journal volume & issue
Vol. 8, no. 2
pp. 41 – 45

Abstract

Read online

Myeloproliferative diseases (MPD) comprise a group of clonalpathology resulting from genetic alterations at a stem cell level.WHO (2008) divides MPD into several classical forms polycythemiavera, essential thrombocytemia, and primary myelofibrosis.Haemorheologic and haemostatic disturbances have beenwidely accepted as a significant (in some cases primary) cause ofacute and/or chronic cerebrovascular disease. A pre-existing MPDmay potentiate and accelerate the development of circulatoryalterations, including those occurring in the brain tissue, leading toischemic stroke. The present article comprises a literature reviewon this uncommon pathology, as well as a clinical presentation of astroke case in a patient with underlying MPD (Vaquez disease).

Keywords